108 related articles for article (PubMed ID: 14600840)
1. Catechins and the treatment of breast cancer: possible utility and mechanistic targets.
Rosengren RJ
IDrugs; 2003 Nov; 6(11):1073-8. PubMed ID: 14600840
[TBL] [Abstract][Full Text] [Related]
2. Tamoxifen and epigallocatechin gallate are synergistically cytotoxic to MDA-MB-231 human breast cancer cells.
Chisholm K; Bray BJ; Rosengren RJ
Anticancer Drugs; 2004 Oct; 15(9):889-97. PubMed ID: 15457130
[TBL] [Abstract][Full Text] [Related]
3. Epicatechin gallate and catechin gallate are superior to epigallocatechin gallate in growth suppression and anti-inflammatory activities in pancreatic tumor cells.
Kürbitz C; Heise D; Redmer T; Goumas F; Arlt A; Lemke J; Rimbach G; Kalthoff H; Trauzold A
Cancer Sci; 2011 Apr; 102(4):728-34. PubMed ID: 21241417
[TBL] [Abstract][Full Text] [Related]
4. The green tea catechins, (-)-Epigallocatechin-3-gallate (EGCG) and (-)-Epicatechin-3-gallate (ECG), inhibit HGF/Met signaling in immortalized and tumorigenic breast epithelial cells.
Bigelow RL; Cardelli JA
Oncogene; 2006 Mar; 25(13):1922-30. PubMed ID: 16449979
[TBL] [Abstract][Full Text] [Related]
5. A new role for tamoxifen in oestrogen receptor-negative breast cancer when it is combined with epigallocatechin gallate.
Scandlyn MJ; Stuart EC; Somers-Edgar TJ; Menzies AR; Rosengren RJ
Br J Cancer; 2008 Oct; 99(7):1056-63. PubMed ID: 18797454
[TBL] [Abstract][Full Text] [Related]
6. Cancer Therapy by Catechins Involves Redox Cycling of Copper Ions and Generation of Reactive Oxygen species.
Farhan M; Khan HY; Oves M; Al-Harrasi A; Rehmani N; Arif H; Hadi SM; Ahmad A
Toxins (Basel); 2016 Feb; 8(2):37. PubMed ID: 26861392
[TBL] [Abstract][Full Text] [Related]
7. Tea catechin synergies in inhibition of cancer cell proliferation and of a cancer specific cell surface oxidase (ECTO-NOX).
Morré DJ; Morré DM; Sun H; Cooper R; Chang J; Janle EM
Pharmacol Toxicol; 2003 May; 92(5):234-41. PubMed ID: 12753411
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effects of (--)-epigallocatechin gallate with (--)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9.
Suganuma M; Okabe S; Kai Y; Sueoka N; Sueoka E; Fujiki H
Cancer Res; 1999 Jan; 59(1):44-7. PubMed ID: 9892181
[TBL] [Abstract][Full Text] [Related]
9. Interaction of green tea catechins with breast cancer endocrine treatment: a systematic review.
Yiannakopoulou EC
Pharmacology; 2014; 94(5-6):245-8. PubMed ID: 25471334
[TBL] [Abstract][Full Text] [Related]
10. Green tea and its catechins inhibit breast cancer xenografts.
Sartippour MR; Heber D; Ma J; Lu Q; Go VL; Nguyen M
Nutr Cancer; 2001; 40(2):149-56. PubMed ID: 11962250
[TBL] [Abstract][Full Text] [Related]
11. Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancer.
Liang G; Tang A; Lin X; Li L; Zhang S; Huang Z; Tang H; Li QQ
Int J Oncol; 2010 Jul; 37(1):111-23. PubMed ID: 20514403
[TBL] [Abstract][Full Text] [Related]
12. (-)-Epigallocatechin-3-gallate downregulates estrogen receptor alpha function in MCF-7 breast carcinoma cells.
Farabegoli F; Barbi C; Lambertini E; Piva R
Cancer Detect Prev; 2007; 31(6):499-504. PubMed ID: 18061364
[TBL] [Abstract][Full Text] [Related]
13. Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate.
Liao S; Umekita Y; Guo J; Kokontis JM; Hiipakka RA
Cancer Lett; 1995 Sep; 96(2):239-43. PubMed ID: 7585463
[TBL] [Abstract][Full Text] [Related]
14. Combinatorial bioactive botanicals re-sensitize tamoxifen treatment in ER-negative breast cancer via epigenetic reactivation of ERα expression.
Li Y; Meeran SM; Tollefsbol TO
Sci Rep; 2017 Aug; 7(1):9345. PubMed ID: 28839265
[TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis in human stomach cancer cells by green tea catechins.
Hibasami H; Komiya T; Achiwa Y; Ohnishi K; Kojima T; Nakanishi K; Akashi K; Hara Y
Oncol Rep; 1998; 5(2):527-9. PubMed ID: 9468594
[TBL] [Abstract][Full Text] [Related]
16. Potential mechanisms for the synergistic cytotoxicity elicited by 4-hydroxytamoxifen and epigallocatechin gallate in MDA-MB-231 cells.
Stuart EC; Larsen L; Rosengren RJ
Int J Oncol; 2007 Jun; 30(6):1407-12. PubMed ID: 17487361
[TBL] [Abstract][Full Text] [Related]
17. New cancer treatment strategy using combination of green tea catechins and anticancer drugs.
Suganuma M; Saha A; Fujiki H
Cancer Sci; 2011 Feb; 102(2):317-23. PubMed ID: 21199169
[TBL] [Abstract][Full Text] [Related]
18. Direct interaction of natural and synthetic catechins with signal transducer activator of transcription 1 affects both its phosphorylation and activity.
Menegazzi M; Mariotto S; Dal Bosco M; Darra E; Vaiana N; Shoji K; Safwat AA; Marechal JD; Perahia D; Suzuki H; Romeo S
FEBS J; 2014 Feb; 281(3):724-38. PubMed ID: 24255956
[TBL] [Abstract][Full Text] [Related]
19. Effect of tea catechins on cellular lipid peroxidation and cytotoxicity in HepG2 cells.
Murakami C; Hirakawa Y; Inui H; Nakano Y; Yoshida H
Biosci Biotechnol Biochem; 2002 Jul; 66(7):1559-62. PubMed ID: 12224642
[TBL] [Abstract][Full Text] [Related]
20. Synergistic enhancement of anticancer effects on numerous human cancer cell lines treated with the combination of EGCG, other green tea catechins, and anticancer compounds.
Fujiki H; Sueoka E; Watanabe T; Suganuma M
J Cancer Res Clin Oncol; 2015 Sep; 141(9):1511-22. PubMed ID: 25544670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]